community yet another landscape with which to discriminate between those embryos most desirable for transfer. Bearing in mind that her insights came at a time when discussions as to the optimum stage for transfer presaged the introduction of media extending the developmental window to blastocyst, pronuclear staging filled an important gap in our understanding of the earliest stages of human development. She also was among the first to deploy timelapse imaging, convinced that cellular behaviors at the onecell stage might someday be linked to outcome measures consistent with a term pregnancy. Now comes a report from the laboratory of Dr. Sangita Jindal taking aim at the utility of pronuclear scoring as a biomarker for pregnancy outcome (this issue JARG, Berger et al., 2014, "Embryo quality but not pronuclear score is associated with clinical pregnancy following IVF" DOI 10. 1007/s10815-013-0162-3). Using more contemporary biomarkers of embryo quality such as cell number, fragmentation, and blastomere symmetry, the results clearly indicate that the application of pronuclear scoring offers no additional benefit over the use of the accepted measures cited above in terms of clinical pregnancy rates in Day 3 transfers. While putting to rest one approach to embryo scoring, and validating the use of criteria in Day 3 embryos firmly entrenched in the formative events of compaction and cavitation, this work also sets the stage for a new perspective on embryo quality assessment consonant with extending the culture period to Day 5 or 6 for embryo transfer.
Why? Because along with extended culture comes the opportunity to track and deconstruct the details of individual preimplantation embryos under the watchful "eyes" of timelapse imaging while cohorts of concepti make their merry way to the day of transfer content in their isolation in microdrops of media designed to recapitulate the female reproductive tract. It is undeniable that the introduction of dynamic imaging brings an analytical array of benchmarks to the prognosticators' playbook. It is far less apparent to what extent the "criteria under development" will indeed offer more reliable and accurate indices of embryo quality.
Here at JARG, we remain mindful of the historical traces of gamete and embryo evaluation that may at the time have satisfied the needs of embryo selection but in the end offer little more when it comes to predicting whether a clinically significant event will ever take place. While as a community of clinicians and scientists eternally optimistic that the perspective of time-lapse imaging will bear fruit as a predictive tool, "proof of the pudding" has yet to be realized. We encourage out readership to maintain focus in the pages of JARG as this next phase of embryo quality assessment matures into what will hopefully become a useful tool.
